Tag Archives: JAMA
The toxic affair between Covaxin and The Lancet
That Covaxin has been leading a ceaselessly beleaguered life is no mystery – but The Lancet journal may not know that it has been pressed into the questionable service of saving the vaccine’s reputation on at least three occasions. In … Continue reading
Posted in Analysis, Science
Tagged Bharat Biotech, clinical trials, Covaxin, JAMA, New England Journal of Medicine, retraction index, scientific publishing, The Lancet
Comments Off on The toxic affair between Covaxin and The Lancet